Les Sulewski
Stock Analyst at Truist Securities
(1.08)
# 3,875
Out of 5,140 analysts
15
Total ratings
53.85%
Success rate
-14.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $6.65 | +20.30% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $20.24 | +38.34% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $47.01 | +2.11% | 3 | Nov 7, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $31.41 | -20.41% | 1 | May 28, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $13.71 | -12.47% | 3 | Oct 2, 2024 |
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $6.65
Upside: +20.30%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $20.24
Upside: +38.34%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $47.01
Upside: +2.11%
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $31.41
Upside: -20.41%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $13.71
Upside: -12.47%